Pre Tax Profit változás Dátum
Acadia Pharmaceuticals USD 39.7M 91.85M 2023-12
Aceragen USD -11055000 20.19M 2022-12
Agios Pharmaceuticals USD -95940000 4.62M 2023-12
Alnylam Pharmaceuticals USD -137687000 288.43M 2023-12
Amgen USD 3.03B 153M 2023-12
BioCryst Pharmaceuticals USD -35819000 38.77M 2023-09
Biogen USD 801.7M 231.6M 2023-06
BioMarin Pharmaceutical USD 33.33M 8.34M 2023-12
Bluebird Bio USD -71731000 1.26M 2023-09
Bristol-Myers Squibb USD 4.07B 613M 2023-12
Eli Lilly USD 2.59B 2.27B 2023-12
Exelixis USD 103.04M 97.22M 2023-12
Gilead Sciences USD 2.59B 586M 2023-12
Incyte USD 319.15M 14.94M 2023-09
Ionis Pharmaceuticals USD -3000000 138M 2023-12
Lumos Pharma USD -8300000 660K 2023-09
Merck USD -473000000 6.86B 2023-12
Moderna USD 70M 2.03B 2023-12
Nektar Therapeutics USD -45898000 5.27M 2023-09
Neurocrine Biosciences USD 198.2M 82.6M 2023-12
Pfizer USD -1250000000 5.38B 2023-09
PTC Therapeutics USD -19493000 147.1M 2023-12
Regeneron Pharmaceuticals USD 1.4B 54.4M 2023-12
Sarepta Therapeutics USD -33174000 18.59M 2023-09
Ultragenyx Pharmaceutical USD -126892000 32.11M 2023-12
Vertex Pharmaceuticals USD 1.31B 9.6M 2023-12



Incyte Adózás Előtti Eredmény - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.